Delivery Order SPE2DB22D3501-SPE2DB24FUT33
- Not listed
- This federal contract award, valued at $1,867.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NEXLIZET 180-10 MG TABLET UU 30S, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price agreement, without any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,768.56 with a firm fixed price. It covers the supply of NEXLIZET 180-10 MG TABLET for the DLA, with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,396.07 firm fixed-price delivery order is for NEXLIZET 180-10 MG TABLET supplies, with a completion date of October 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,628.29 firm-fixed-price delivery order is for 4568346973 ! NEXLIZET 180-10 MG TABLET UU 30S, with a performance period extending through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This federal contract award with a ceiling value of $7,482.35 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,364.32, is for the supply of the drug NEXLIZET 180-10 MG TABLET to support U.S. military and federal healthcare programs. It is a firm-fixed-price contract with an ultimate completion date of August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,893.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NEXLIZET 180-10 MG TABLET medical supplies, with a completion date of September 21, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $14,093.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the purchase of NEXLIZET 180-10 MG TABLET in quantities of 30s. This award does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.37 firm fixed-price delivery order contract is for the provision of NEXLIZET 180-10 MG TABLET UU 30S, a medical supply item. The contract has an ultimate completion date of January 27, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUT33Delivery Order
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FUT33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,196.85, is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 29, 2024. It was awarded on February 28, 2024, and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/28/24 |